This map shows the geographic impact of Lars Slørdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Slørdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Slørdal more than expected).
This network shows the impact of papers produced by Lars Slørdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Slørdal. The network helps show where Lars Slørdal may publish in the future.
Co-authorship network of co-authors of Lars Slørdal
This figure shows the co-authorship network connecting the top 25 collaborators of Lars Slørdal.
A scholar is included among the top collaborators of Lars Slørdal based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Lars Slørdal. Lars Slørdal is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Spigset, Olav, et al.. (2008). Benzodiazepinliknende hypnotika – holdninger og forskrivningspraksis blant allmennleger. Tidsskrift for Den Norske Laegeforening.1 indexed citations
7.
Bjordal, Jan Magnus, et al.. (2007). Glukosamin – den store sukkerpillebløffen. Tidsskrift for Den Norske Laegeforening.1 indexed citations
8.
Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). [Clinical use of COX inhibitors--a consensus].. PubMed. 126(5). 591–5.5 indexed citations
9.
Nelson, Siri, Lars Slørdal, & Olav Spigset. (2006). [Generic drugs instead of brand drugs prescriptions--long overdue].. PubMed. 126(4). 441–3.9 indexed citations
10.
Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). Klinisk bruk av COX-hemmere – en konsensus. Tidsskrift for Den Norske Laegeforening.2 indexed citations
11.
Nelson, Siri, Lars Slørdal, & Olav Spigset. (2006). Forskrivning av virkestoff i stedet for preparat – på høy tid. Tidsskrift for Den Norske Laegeforening.1 indexed citations
12.
Slørdal, Lars & Olav Spigset. (2005). Grunnleggende farmakokinetikk – distribusjon. Tidsskrift for Den Norske Laegeforening.2 indexed citations
13.
Slørdal, Lars & Olav Spigset. (2005). Grunnleggende farmakokinetikk – absorpsjon. Tidsskrift for Den Norske Laegeforening.1 indexed citations
14.
Eldholm, Rannveig Sakshaug, et al.. (2003). [What information is given on adverse drug reactions from new drugs?].. PubMed. 123(17). 2414–7.1 indexed citations
15.
Eldholm, Rannveig Sakshaug, et al.. (2003). Hvilken informasjon gis om bivirkninger av nye legemidler. Tidsskrift for Den Norske Laegeforening.1 indexed citations
16.
Spigset, Olav, et al.. (2003). Selektive COX-2-hemmere – holdninger og forskrivningspraksis blant allmennpraktikere. Tidsskrift for Den Norske Laegeforening.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.